6.205
price up icon0.89%   0.015
after-market アフターアワーズ: 6.15 -0.055 -0.89%
loading
前日終値:
$6.19
開ける:
$6.2
24時間の取引高:
759.99K
Relative Volume:
0.33
時価総額:
$373.14M
収益:
$216.11M
当期純損益:
$-220.47M
株価収益率:
-1.6607
EPS:
-3.7363
ネットキャッシュフロー:
$-110.44M
1週間 パフォーマンス:
+4.26%
1か月 パフォーマンス:
-9.36%
6か月 パフォーマンス:
+17.83%
1年 パフォーマンス:
+44.23%
1日の値動き範囲:
Value
$6.12
$6.31
1週間の範囲:
Value
$6.01
$6.31
52週間の値動き範囲:
Value
$4.14
$9.94

Vanda Pharmaceuticals Inc Stock (VNDA) Company Profile

Name
名前
Vanda Pharmaceuticals Inc
Name
セクター
Healthcare (1113)
Name
電話
202-734-3400
Name
住所
2200 PENNSYLVANIA AVE NW, WASHINGTON
Name
職員
533
Name
Twitter
Name
次回の収益日
2026-05-06
Name
最新のSEC提出書
Name
VNDA's Discussions on Twitter

Compare VNDA vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
VNDA icon
VNDA
Vanda Pharmaceuticals Inc
6.205 372.24M 216.11M -220.47M -110.44M -3.7363
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
435.92 110.28B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
634.42 66.98B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
808.61 50.15B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
295.50 39.71B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
154.89 32.22B 742.00K -1.37B -1.07B -7.0731

Vanda Pharmaceuticals Inc Stock (VNDA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-05 開始されました Truist Buy
2025-11-05 開始されました B. Riley Securities Buy
2024-10-31 開始されました H.C. Wainwright Buy
2024-07-11 開始されました Cantor Fitzgerald Overweight
2022-02-25 ダウングレード Jefferies Buy → Hold
2021-05-12 開始されました BofA Securities Buy
2021-01-14 ダウングレード Citigroup Buy → Neutral
2020-10-29 アップグレード Citigroup Neutral → Buy
2020-06-09 ダウングレード Citigroup Buy → Neutral
2020-03-16 ダウングレード Oppenheimer Perform → Underperform
2020-03-12 アップグレード Citigroup Neutral → Buy
2019-11-07 ダウングレード Citigroup Buy → Neutral
2019-08-01 アップグレード Citigroup Neutral → Buy
2019-07-25 ダウングレード Stifel Buy → Hold
2018-12-11 ダウングレード Oppenheimer Outperform → Perform
2018-12-04 アップグレード Cantor Fitzgerald Neutral → Overweight
2018-12-04 繰り返されました Jefferies Buy
2018-11-08 再開されました Jefferies Buy
2018-09-21 再開されました Oppenheimer Outperform
2018-05-23 開始されました Citigroup Buy
2018-01-19 開始されました Seaport Global Securities Buy
2017-09-14 繰り返されました Piper Jaffray Overweight
2017-06-27 再開されました Piper Jaffray Overweight
2017-05-26 開始されました H.C. Wainwright Buy
2017-04-12 開始されました Oppenheimer Outperform
2016-11-09 開始されました Aegis Capital Buy
2016-10-06 再開されました Jefferies Buy
すべてを表示

Vanda Pharmaceuticals Inc (VNDA) 最新ニュース

pulisher
May 23, 2026

Vanda a new buy at B. Riley on 'historic discount' - MSN

May 23, 2026
pulisher
May 20, 2026

Vanda Pharmaceuticals Q3 Earnings Preview - MSN

May 20, 2026
pulisher
May 20, 2026

Vanda (VNDA) director donates 25,836 shares of common stock - Stock Titan

May 20, 2026
pulisher
May 19, 2026

VNDA: 2026 revenue guidance raised on new launches, with BYSANTI and NEREUS set to drive future growth - TradingView

May 19, 2026
pulisher
May 17, 2026

How The Vanda Pharmaceuticals (VNDA) Investment Story Is Shifting With BYSANTI And Nereus - Yahoo Finance

May 17, 2026
pulisher
May 16, 2026

Vanda Pharmaceuticals stock (US92178N1054): Regulatory setback, sharp drop and rising short interest - AD HOC NEWS

May 16, 2026
pulisher
May 13, 2026

Vanda: A Long-Term Pharma Growth Idea, Despite Q1 Earnings Miss (NASDAQ:VNDA) - Seeking Alpha

May 13, 2026
pulisher
May 13, 2026

Vanda targets $240M-$290M 2026 revenue as it introduces $10M-$30M NEREUS sales outlook - MSN

May 13, 2026
pulisher
May 13, 2026

HC Wainwright Brokers Lower Earnings Estimates for VNDA - MarketBeat

May 13, 2026
pulisher
May 12, 2026

State Street (VNDA) discloses 3.02M shares, 5.1% ownership on 13G - Stock Titan

May 12, 2026
pulisher
May 12, 2026

Earnings call transcript: Vanda Pharmaceuticals Q1 2026 misses EPS forecast, stock drops By Investing.com - Investing.com South Africa

May 12, 2026
pulisher
May 12, 2026

Earnings call transcript: Vanda Pharmaceuticals Q1 2026 misses EPS forecast, stock drops - Investing.com Nigeria

May 12, 2026
pulisher
May 11, 2026

H.C. Wainwright cuts Vanda Pharmaceuticals stock price target on higher costs - Investing.com UK

May 11, 2026
pulisher
May 11, 2026

H.C. Wainwright Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Cuts Target Price to $21 - Moomoo

May 11, 2026
pulisher
May 11, 2026

VNDA Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus

May 11, 2026
pulisher
May 11, 2026

HC Wainwright Cuts Vanda Pharmaceuticals (NASDAQ:VNDA) Price Target to $21.00 - MarketBeat

May 11, 2026
pulisher
May 11, 2026

H.C. Wainwright cuts Vanda Pharmaceuticals stock price target on higher costs By Investing.com - Investing.com South Africa

May 11, 2026
pulisher
May 09, 2026

Vanda Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript - GuruFocus

May 09, 2026
pulisher
May 08, 2026

VNDA SEC FilingsVanda Pharma 10-K, 10-Q, 8-K Forms - Stock Titan

May 08, 2026
pulisher
May 08, 2026

Vanda Pharmaceuticals Announces Participation at May 2026 Investor Conferences - BioSpace

May 08, 2026
pulisher
May 08, 2026

Vanda Pharmaceuticals (VNDA) Losses Deepen To US$239.5 Million LTM Reinforcing Bearish Narratives - Sahm

May 08, 2026
pulisher
May 07, 2026

VNDA Reports Strong Q1 Growth with New Product Launches - GuruFocus

May 07, 2026
pulisher
May 07, 2026

VNDA Projected Revenue Forecast for 2026 at $258.2 Million - GuruFocus

May 07, 2026
pulisher
May 07, 2026

Vanda Pharmaceuticals 1Q Loss/Shr 82c >VNDA - Moomoo

May 07, 2026
pulisher
May 07, 2026

Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences - Intellectia AI

May 07, 2026
pulisher
May 07, 2026

Truist Financial Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Announces Target Price $18 - Moomoo

May 07, 2026
pulisher
May 07, 2026

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2026 Earnings Call Transcript - Insider Monkey

May 07, 2026
pulisher
May 07, 2026

[10-Q] Vanda Pharmaceuticals Inc. Quarterly Earnings Report - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Vanda Pharmaceuticals Q1 Earnings Call Highlights - Yahoo Finance

May 07, 2026
pulisher
May 07, 2026

Vanda: Q1 Earnings Snapshot - theheraldreview.com

May 07, 2026
pulisher
May 07, 2026

Vanda maps out 3 May investor events, including a live webcast - Stock Titan

May 07, 2026
pulisher
May 06, 2026

MSN Money - MSN

May 06, 2026
pulisher
May 06, 2026

Earnings call transcript: Vanda Pharmaceuticals misses Q1 2026 forecasts, stock rises By Investing.com - Investing.com South Africa

May 06, 2026
pulisher
May 06, 2026

Vanda Pharmaceuticals Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 06, 2026
pulisher
May 06, 2026

Earnings call transcript: Vanda Pharmaceuticals misses Q1 2026 forecasts, stock rises - Investing.com Nigeria

May 06, 2026
pulisher
May 06, 2026

Vanda (VNDA) Q1 2026 Earnings Call Transcript - The Globe and Mail

May 06, 2026
pulisher
May 06, 2026

Document - SEC.gov

May 06, 2026
pulisher
May 06, 2026

VANDA PHARMACEUTICALS INC (NASDAQ:VNDA) Misses Q1 2026 Estimates as Top-Line Growth Slows - ChartMill

May 06, 2026
pulisher
May 06, 2026

Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

May 06, 2026
pulisher
May 06, 2026

Vanda Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

May 06, 2026
pulisher
May 06, 2026

VANDA PHARMACEUTICALS ($VNDA) Releases Q1 2026 Earnings - Quiver Quantitative

May 06, 2026
pulisher
May 06, 2026

Q1 2026 Vanda Pharmaceuticals Inc Earnings Call Transcript - GuruFocus

May 06, 2026
pulisher
May 06, 2026

Vanda Pharmaceuticals (NASDAQ: VNDA) boosts 2026 revenue view on new approvals - Stock Titan

May 06, 2026
pulisher
May 06, 2026

Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results - marketscreener.com

May 06, 2026
pulisher
May 06, 2026

Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results – Company Announcement - Financial Times

May 06, 2026
pulisher
May 06, 2026

[EFFECT] Vanda Pharmaceuticals Inc. SEC Filing - Stock Titan

May 06, 2026
pulisher
May 06, 2026

How many employees work at Vanda Pharmaceuticals? - reveliolabs.com

May 06, 2026
pulisher
May 06, 2026

Vanda Pharmaceuticals Inc. Raises Revenue Guidance for the Full-Year 2026 - marketscreener.com

May 06, 2026
pulisher
May 05, 2026

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 - Quantisnow

May 05, 2026

Vanda Pharmaceuticals Inc (VNDA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Vanda Pharmaceuticals Inc (VNDA) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Moran Kevin Patrick
SVP, CFO & Treasurer
Mar 02 '26
Sale
8.27
42,442
350,821
411,380
Wijkstrom Joakim
SVP, Chief Marketing Officer
Mar 02 '26
Sale
8.27
30,800
254,590
333,469
Polymeropoulos Mihael Hristos
President and CEO
Mar 02 '26
Sale
8.17
156,235
1,276,971
2,704,496
Birznieks Gunther
SVP, Business Development
Mar 02 '26
Sale
8.27
42,431
350,730
494,197
$29.66
price down icon 1.49%
$92.29
price up icon 0.12%
$108.87
price up icon 2.60%
$53.85
price down icon 0.94%
ONC ONC
$302.59
price down icon 2.50%
$154.89
price up icon 2.21%
大文字化:     |  ボリューム (24 時間):